SCORE ENDOSCOPICI PER LE IBD ! UNA OTTIMA REVISIONE DALL'”AMERICAN GASTROENTEROLOGY ASSOCIATION”. DA “GASTROENTEROLOGY” (FREE)

AGA Clinical Practice Update on Endoscopic Scoring Systems in Inflammatory Bowel Disease: Commentary Anna M. Buchner∙ Francis A. Farraye ∙ Marietta Iacucci Abstract Descrizione I sistemi di punteggio endoscopici valutano la gravità dell’infiammazione e forniscono obiettività, uniformità e standardizzazione della segnalazione degli aspetti della mucosa nei pazienti con malattia infiammatoria intestinale; pertanto, sono stati consigliati per valutare l’efficacia…

ACCESSO ENTERALE PER VIA ENDOSCOPICA: UNA BUONA REVISIONE DELL’ “AMERICAN SOCIETY FOR GASTROENTEROLOGY”! DA” GASTROENTEROLOGY” (FREE)

AGA Clinical Practice Update on Endoscopic Enteral Access: Commentary Dejan Micic et al. Abstract Description The purpose of this American Gastroenterological Association (AGA) Clinical Practice Update is to facilitate understanding and improve the clinical practice of endoscopic enteral access. Methods This expert commentary was commissioned and approved by the AGA Institute Clinical Practice Updates Committee…

MA L’INTELLIGENZA ARTIFICIALE MIGLIORA LA PERFORMANCE DELLA COLONSCOPIA NELLA IDENTIFICAZIONE DEI POLIPI ? UNA GRANDE META-ANALISI ! DA “GASTROINTESTINAL ENDOSCOPY” (FREE)

Use of artificial intelligence improves colonoscopy performance in adenoma detection: a systematic review and meta-analysis Jonathan Makar et al. Abstract Background and aims: Artificial intelligence (AI) is increasingly used to improve adenoma detection during colonoscopy. This meta-analysis aimed to provide an updated evaluation of computer-aided detection (CADe) systems and their impact on key colonoscopy quality indicators.…

GESTIONE DELLA DIETA NEL COLON IRRITABILE. UNA GRANDE REVIEW SU “LANCET GASTROENTEROLGY & HEPATOLOGY”

Dietary management of irritable bowel syndrome: considerations, challenges, and solutions Kevin Whelan et al. Diet is a cornerstone in the management of irritable bowel syndrome (IBS). There is evidence of efficacy across the spectrum of dietary management strategies, including some supplements (eg, specific fibres), foods, and whole diets (eg, a diet low in fermentable oligosaccharides,…

GESTIRE I SINTOMI NELLE IBD ! UNA GRANDE SFIDA ! DA “GUT”

Recent advances in clinical practice: mastering the challenge—managing IBS symptoms in IBD Judith Wellens et al. ABSTRACT Many patients with IBD report persisting symptoms, despite resolution of the inflammatory process. Although by definition, a diagnosis of IBS cannot be made, the prevalence of ’IBS in IBD’ surpasses the rate of IBS in the global population by…

ATTENZIONE ! PRIMARY BILIARY CHOLANGITIS: ARRIVA ANCHE ELAFIBRANOR IN SECONDA LINEA. UN GRANDE TRIAL FASE 3 DA “THE NEW ENGLAND JOURNAL OF MEDICINE” (FREE)

Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis Kris V. Kowdley et al. Abstract Background Primary biliary cholangitis is a rare, chronic cholestatic liver disease characterized by the destruction of interlobular bile ducts, leading to cholestasis and liver fibrosis. Whether elafibranor, an oral, dual peroxisome proliferator-activated receptor (PPAR) α and δ agonist, may have…